Company profile
GT Apeiron Therapeutics company profile
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational medicines by harnessing the power of artificial intelligence, aiming to drastically increase efficiency throughout the drug discovery process.
Business identity
- Website
- https://www.apeiron-bio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Shaxi, Fujian, China
- Country code
- CN
- Continent
- Asia